Skip to main content

Animations

MJFF Publications

621 - 630 of 6433 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With Gliosis
    Journal Name: Journal of the American Heart Association
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1161/jaha.120.019627
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    Journal Name: Pharmacogenetics and Genomics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Measuring Structural Racism: A Guide for Epidemiologists and Other Health Researchers
    Journal Name: American Journal of Epidemiology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/aje/kwab239
    Citation Count: 299
  • Summary Details
    OPEN
    Title: Orofacial pain in 1916 patients with early or moderate Parkinson disease
    Journal Name: PAIN Reports
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1097/pr9.0000000000000923
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab404
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Dying-back of ascending noradrenergic projections in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab286
    Citation Count: 6
  • Summary Details
    OPEN
    Title: An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bib/bbab522
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network
    Journal Name: Cerebral Cortex
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/cercor/bhab148
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/hmg/ddab118
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.